Category: Cancer Treatment
North America Cancer Treatment
-
Multiple Myeloma Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Smoldering (indolent) Multiple Myeloma, Active (Symptomatic) Multiple Myeloma); By Treatment (Chemotherapy, Targeted Therapy, Immunomodulatory Drugs, Steroids, Bone-Modifying Drugs, Immunotherapy, Bone Marrow/Stem Cell Transplantation, Radiation Therapy, Surgery); By Diagnosis (Blood & Urine Tests, X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT/CAT) Scan, Positron Emission Tomography (PET)/ PET-CT Scan, Bone Marrow Aspiration & Biopsy, Fat Pad Aspirate, Biomarker Testing of the Tumor); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Immunotherapy, Bone Marrow/Stem Cell Transplantation, Radiation Therapy, Surgery); By Diagnosis (Blood & Urine Tests, X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT/CAT) Scan, Positron Emission Tomography (PET)/ PET-CT Scan, Bone Marrow Aspiration & Biopsy, Fat ... Read More
-
Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic Centers, Cancer Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Latin America, Europe, Asia Pacific, Middle East & Africa) Radioactive Tracer Market, By Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Others), By Application (Oncology, Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology, Others), By End User (Hospitals, Diagnostic ... Read More
-
2023-2027 Mexico Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 U.S. Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 North America Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - US, Canada, Mexico - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 3-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
United States Prostate Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... States market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the United States market. Also, factors that are driving and restraining the prostate cancer market are highlighted in the ... Read More
-
North America Colorectal Cancer Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality [Imaging Tests (Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Capsule Endoscopy, and Others) and Stool-Based Tests (Faecal Immunochemical Test (FIT), Guaiac-Based Faecal Occult Blood Test, and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)
... (FIT), Guaiac-Based Faecal Occult Blood Test, and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others) The North America colorectal cancer diagnostics market was valued at US$ 4,315.86 million in ... Read More
-
North America Medical Marijuana Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
... Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others) The North America medical marijuana market is expected to grow from US$ 7,170.17 million in 2022 to US$ 20,760.41 million by 2028. It is ... Read More
-
United States Pancreatic Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... States market. Moreover, the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the United States market. Also, factors that are driving and restraining the pancreatic cancer market are highlighted in the ... Read More
-
US and Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral Vectors and Non-Viral Vectors)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country
... Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Country The US and Europe cell and gene therapy manufacturing services market was valued at ... Read More
-
Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global cancer biomarkers market is poised for significant growth and expansion in the upcoming years. Cancer biomarkers play a crucial role in early detection, diagnosis, and cancer monitoring applications by indicating the presence of cancer ... Read More
-
Myelofibrosis Treatment Market by Type (Targeted therapy, Chemotherapy and Others), Distribution Channel (Hospital pharmacies, Retail and specialty pharmacies and Online pharmacies) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2027
... unusual type of blood cancer. The bone marrow becomes scarred, which makes it complicated to make blood cells. It belongs to a group of diseases referred as myeloproliferative disorders or myeloproliferative neoplasms. Stem cells are ... Read More
-
Non-Small Cell Lung Cancer Market by Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Others and Adenocarcinoma), Treatment Type (Chemotherapy, Targeted Therapy and Immunotherapy), Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy and Online Pharmacy) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027
... and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027 Non-small cell lung cancer is a form of lung cancer, where malignant tumor cells are formed in the lungs. It comprises of ... Read More
-
Fc Fusion Therapeutics Market, 2021-2030 Distribution by Target Indications (Neutropenia, Graft Versus Host Disease, Breast Cancer, Rheumatoid Arthritis, Non-Small Cell Lung Cancer, Neovascular (Wet) Age-related Macular Degeneration (AMD), Hemophilia A, Neuromyelitis Optica Spectrum Disorders and Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030
... Systemic Lupus Erythematosus), Type of Fusion Molecule (Antibody, Cytokine, Growth Factor, Receptor ECD and Others), Route of Administration (Subcutaneous, Intravenous and Intravitreal) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): ... Read More
-
North America Skin Cancer Diagnostics Market Forecast 2023-2032
... by heavy R&D investments and a rapid increase in melanoma cases in the region. MARKET INSIGHTS The North America skin cancer diagnostics market growth evaluation covers a thorough assessment of Canada and the United States. ... Read More
-
US Helicobacter Pylori Non-Invasive Testing Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Test Type (Urea Breath, Test Method, and Serology), Test Method (Laboratories Based and Point of Care), and End User (Hospitals, Reference Laboratories, and Others)
... (Hospitals, Reference Laboratories, and Others) The US Helicobacter Pylori Non-Invasive Testing Market size is expected to grow from US$ 223.76 million in 2022 to US$ 302.79 million by 2028; it is estimated to record a ... Read More
-
Mexico Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030
... is a comprehensive databook report, covering key procedures data on the Mexico Procedures Using Implantable Ports. The databook report provides procedure volumes within segments - Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed ... Read More
-
United States of America (USA) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... Forecast to 2030 Summary GlobalData’s “United States Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United States Embolization Particle Procedures. The databook report provides procedure volumes ... Read More
-
Canada Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Canada Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Canada Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Mexico Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Mexico Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uter
... Summary GlobalData’s “North America Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the North America Embolization Particle Procedures. The databook report provides procedure volumes within segments - ... Read More
-
U.S. Minor Cannabinoids Market Size, Share & Trends Analysis Report By Product (Cannabigerol (CBG), Tetrahydrocannabivarin (THCV)), By Application (Cancer, Inflammation, Pain Management), And Segment Forecasts, 2023 - 2030
... The U.S. minor cannabinoids market size is expected to reach USD 33.3 billion by 2030, expanding at a CAGR of 16.4% over the forecast period, according to a new report by Grand View Research, Inc. ... Read More
-
Molecular Cytogenetics Market, By Product Type (Instruments, Consumables, Software and Services), By Technology (FISH, aCGH), By Application (Genetic Disorder, Cancer, Personalized Medicine, Others.), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Asia Pacific)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Molecular cytogenetics encompasses the combination of molecular biology and cytogenetics. Molecular cytogenetics includes all the aspects of chromosome biology with a wide range of ... Read More
-
North America Skin Cancer Dermatology Market: Current Analysis and Forecast (2022-2028)
... form a mass or tumor. Skin cancer is usually caused by exposure to ultraviolet (UV) radiation from the sun or tanning beds. Skin cancer is typically diagnosed by a dermatologist, who can perform a skin ... Read More
-
U.S. Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2030. Market Segmentation U.S. Pancreatic Cancer Diagnostics Market, By Test ... Read More
Research Assistance
